Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > x sites, y patients, always underwhelming

<< Previous

Bullboard Posts

Next >>

Comment by ChesterLiveson Nov 08, 2023 4:12pm

154 Views

Post# 35724520

RE:RE:x sites, y patients, always underwhelming

I don't think anybody, in the company or shareholder, is pleased with the pace of enrolment. How could anybody be.

Having said that, to suggest there is only a very small market for PMX is to suggest that you know more than Baxter about market size/potential.

I think I'll defer to Baxter on that one.

<< Previous

Bullboard Posts

Next >>

Two Venture-listed mining stocks file NI 43-101 reports